Literature DB >> 10631943

Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation.

J Reimann1, R Schirmbeck.   

Abstract

The concept of distinct endogenous and exogenous pathways for generating peptides for MHC-I and MHC-II-restricted presentation to CD4+ or CD8+ T cells fits well with the bulk of experimental data. Nevertheless, evidence is emerging for alternative processing pathways that generate peptides for MHC-I-restricted presentation. Using a well characterized, particulate viral antigen of prominent medical importance (the hepatitis B surface antigen), we summarize our evidence that the efficient, endolysosomal processing of exogenous antigens can lead to peptide-loaded MHC-I molecules. In addition, we describe evidence for endolysosomal processing of mutant, stress protein-bound, endogenous antigens that liberate peptides binding to (and presented by) MHC-I molecules. The putative biological role of alternative processing of antigens generating cytotoxic T-lymphocyte-stimulating epitopes is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631943     DOI: 10.1111/j.1600-065x.1999.tb01362.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  25 in total

1.  Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.

Authors:  J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus.

Authors:  Yunjung Cho; Sameh Basta; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo.

Authors:  Yu-Zhang Wu; Jian-Ping Zhao; Ying Wan; Zheng-Cai Jia; Wei Zhou; Jiang Bian; Bing Ni; Li-Yun Zou; Yan Tang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Human immunodeficiency virus-like particles activate multiple types of immune cells.

Authors:  Gangadhara Sailaja; Ioanna Skountzou; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2007-02-05       Impact factor: 3.616

5.  Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses.

Authors:  D Chen; K F Weis; Q Chu; C Erickson; R Endres; C R Lively; J Osorio; L G Payne
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.

Authors:  Xiugen Zhang; Farah Cassis-Ghavami; Mike Eller; Jeff Currier; Bonnie M Slike; Xuemin Chen; James Tartaglia; Mary Marovich; Paul Spearman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Authors:  Suresh Pallikkuth; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  Clin Vaccine Immunol       Date:  2007-09

8.  Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.

Authors:  Qin Lizeng; Charlotta Nilsson; Samer Sourial; Sören Andersson; Olav Larsen; Peter Aaby; Mariethe Ehnlund; Ewa Björling
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Melanosomes and MHC class II antigen-processing compartments: a tinted view of intracellular trafficking and immunity.

Authors:  Michael S Marks; Alexander C Theos; Graça Raposo
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.

Authors:  D Marsac; D Loirat; C Petit; O Schwartz; M-L Michel
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.